Explore the latest developments concerning Doctors question evidence.
Doctors question evidence behind Pentagon plan for testosterone screening | US military
Pete Hegseth announced that soldiers aged 30 and older in the US military will be screened for low testosterone
The US defense secretary, Pete Hegseth, this week ordered an annual testosterone-deficiency screening for active-duty and reserve service members aged 30 and older, which he says will help to maintain military readiness.
But many medical professionals warn it might do nothing of the sort and instead could increase service members’ risk of infertility or lead to other consequences if testosterone is prescribed inappropriately.
The mandate is one of several recent healthcare policy changes implemented by Hegseth and other Trump administration cabinet officials that have sparked debate among experts and raised questions about what scientific basis, if any, supports them.
Hegseth Is Pushing Testosterone. The VA Has Already Struggled With the Treatment.
“Men who take testosterone will have a reduction in their sperm counts,” one medical professor said. There’s no stated plan for continuing care.
Providing continuing hormone-replacement therapy at “the High-T Department of War,” as Secretary Pete Hegseth is calling it, may prove difficult for the federal government because the department in charge of healthcare for veterans has already documented a struggle to manage service members’ hormone therapy, The Intercept has found.
A person on testosterone therapy can’t just stop it abruptly. Dr. Adrian Dobs, a professor of medicine and oncology at Johns Hopkins University School of Medicine, told The Intercept testosterone therapy can suppress the body’s natural production of the hormone and sperm, as well as create medical needs that persist after treatment stops. “We’re sort of creating a dependency on testosterone,” she said.
Shake-N-Go Glossy Virgin Remy Hair Weave 3 Bundles Straight – Natural Shine, Full Volume, Soft Texture, Easy to Style
Judge questions difference between Hegseth’s testosterone policy and transgender care for troops
U.S. District Judge Ana Reyes in Washington raised the question Wednesday in an ongoing lawsuit against President Donald Trump's ban on transgender troops.
WASHINGTON (AP) — Defense Secretary Pete Hegseth’s new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement therapy and hormone treatment for transgender men in the military.
U.S. District Judge Ana Reyes in Washington raised the question Wednesday in an ongoing lawsuit against President Donald Trump’s ban on transgender troops. Reyes noted that Trump’s ban says “the Armed Forces must adhere to high mental and physical health standards … without the benefit of routine medical treatment or special provisions.”
For more detailed information, explore updates concerning Doctors question evidence.
0 Comments